{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:51:41Z","timestamp":1786719101014,"version":"build-2736575974"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Taiwan J Ophthalmol"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/tjo.tjo_62_18","type":"journal-article","created":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T02:29:13Z","timestamp":1548642553000},"page":"255","source":"Crossref","is-referenced-by-count":5,"title":["Treatment outcomes of zone 1 retinopathy of prematurity: A study from a tertiary eye care center in South India"],"prefix":"10.4103","volume":"9","author":[{"given":"Parveen","family":"Sen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharanya","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smriti","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingam","family":"Gopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod","family":"Bhende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2211-5056.250964-1","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1395-3907.2003.00171.x","article-title":"Outcome of zone 1 retinopathy of prematurity","author":"O'Keefe","year":"2003","journal-title":"Acta Ophthalmol Scand"},{"key":"key-10.4103\/2211-5056.250964-2","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1097\/IAE.0b013e3181ca1457","article-title":"Treatment of type 1 retinopathy of prematurity with intravitreal bevacizumab (Avastin)","author":"Dorta","year":"2010","journal-title":"Retina"},{"key":"key-10.4103\/2211-5056.250964-3","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jaapos.2013.12.003","article-title":"Risk factors and rate of progression for zone I versus zone II type 1 retinopathy of prematurity","author":"Shin","year":"2014","journal-title":"J AAPOS"},{"key":"key-10.4103\/2211-5056.250964-4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ajo.2008.05.010","article-title":"Progression and timing of treatment of zone I retinopathy of prematurity","author":"Soh","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/2211-5056.250964-5","first-page":"195","article-title":"Multicentric trial of retinopathy of prematurity: Three-month outcome","author":"Cryotherapy","year":"1990","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/2211-5056.250964-6","first-page":"1684","article-title":"Revised indications for the treatment of retinopathy of prematurity: Results of the early treatment for retinopathy of prematurity randomized trial","author":"Early","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/2211-5056.250964-7","doi-asserted-by":"crossref","unstructured":"Gonzales CR, Boshra J, Schwartz SD 25-gauge pars plicata vitrectomy for stage 4 and 5 retinopathy of prematurity. Retina 2006;26:S42-6.","DOI":"10.1097\/01.iae.0000244288.63757.be"},{"key":"key-10.4103\/2211-5056.250964-8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4103\/0301-4738.53050","article-title":"Functional and anatomical outcomes after primary lens-sparing pars plana vitrectomy for stage 4 retinopathy of prematurity","author":"Bhende","year":"2009","journal-title":"Indian J Ophthalmol","ISSN":"https:\/\/id.crossref.org\/issn\/0301-4738","issn-type":"print"},{"key":"key-10.4103\/2211-5056.250964-9","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ophtha.2014.11.004","article-title":"Long-term outcomes on lens clarity after lens-sparing vitrectomy for retinopathy of prematurity","author":"Nudleman","year":"2015","journal-title":"Ophthalmology"},{"key":"key-10.4103\/2211-5056.250964-10","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity","author":"Mintz-Hittner","year":"2011","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2211-5056.250964-11","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/IAE.0000000000000380","article-title":"Intravitreal anti-vascular endothelial growth factor treatment for retinopathy of prematurity: Comparison between ranibizumab and bevacizumab","author":"Chen","year":"2015","journal-title":"Retina"},{"key":"key-10.4103\/2211-5056.250964-12","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000338623","article-title":"Combination of intravitreal ranibizumab and laser photocoagulation for aggressive posterior retinopathy of prematurity","author":"Mota","year":"2012","journal-title":"Case Rep Ophthalmol"},{"key":"key-10.4103\/2211-5056.250964-13","first-page":"991","article-title":"The international classification of retinopathy of prematurity revisited","author":"International","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/2211-5056.250964-14","unstructured":"Pejawar R, Vinekar A, Bilagi A. National Neonatology Foundation's Evidence- based Clinical Practise Guidelines 2010. Retinopathy of Prematurity. New Delhi: NNF India; 2010. p. 253-62."},{"key":"key-10.4103\/2211-5056.250964-15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4103\/0301-4738.71689","article-title":"Technical aspects of laser treatment for acute retinopathy of prematurity under topical anesthesia","author":"Jalali","year":"2010","journal-title":"Indian J Ophthalmol","ISSN":"https:\/\/id.crossref.org\/issn\/0301-4738","issn-type":"print"},{"key":"key-10.4103\/2211-5056.250964-16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/pr.2013.205","article-title":"Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010","author":"Blencowe","year":"2013","journal-title":"Pediatr Res"},{"key":"key-10.4103\/2211-5056.250964-17","first-page":"137","article-title":"The mode of development of the vascular system of the retina, with some observations in its significance for certain retinal diseases","author":"Michaelson","year":"1984","journal-title":"Trans Ophthalmol Soc UK"},{"key":"key-10.4103\/2211-5056.250964-18","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/bjo.38.7.397","article-title":"Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia","author":"Ashton","year":"1954","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/2211-5056.250964-19","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ajo.2010.10.007","article-title":"Outcomes of a protocol-based management for zone 1 retinopathy of prematurity: The Indian twin cities ROP screening program report number 2","author":"Jalali","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/2211-5056.250964-20","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s12098-009-0175-1","article-title":"Severe retinopathy of prematurity in big babies in India: History repeating itself?","author":"Shah","year":"2009","journal-title":"Indian J Pediatr"},{"key":"key-10.4103\/2211-5056.250964-21","doi-asserted-by":"crossref","first-page":"e518","DOI":"10.1542\/peds.2004-1180","article-title":"Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: Implications for screening programs","author":"Gilbert","year":"2005","journal-title":"Pediatrics"},{"key":"key-10.4103\/2211-5056.250964-22","first-page":"331","article-title":"Retinopathy of prematurity in Asian Indian babies weighing greater than 1250 grams at birth: Ten year data from a tertiary care center in a developing country","author":"Vinekar","year":"2007","journal-title":"Indian J Ophthalmol","ISSN":"https:\/\/id.crossref.org\/issn\/0301-4738","issn-type":"print"},{"key":"key-10.4103\/2211-5056.250964-23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ajo.2012.07.012","article-title":"Aggressive posterior retinopathy of prematurity: Risk factors for retinal detachment despite confluent laser photocoagulation","author":"Sanghi","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/2211-5056.250964-24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3928\/01913913-20131112-02","article-title":"Diode laser photocoagulation for retinopathy of prematurity: Outcomes after 7 years of treatment","author":"Nicoara","year":"2014","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"key-10.4103\/2211-5056.250964-25","first-page":"S15","article-title":"Combine intravitreal bevacizumab injection with laser treatment for aggressive posterior retinopathy of prematurity (AP-ROP)","author":"Wutthiworawong","year":"2011","journal-title":"J Med Assoc Thai"},{"key":"key-10.4103\/2211-5056.250964-26","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s00417-010-1430-x","article-title":"Intravitreal bevacizumab in combination with laser therapy for the treatment of severe retinopathy of prematurity (ROP) associated with vitreous or retinal hemorrhage","author":"Nazari","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/2211-5056.250964-27","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.ophtha.2016.04.028","article-title":"Clinical management of recurrent retinopathy of prematurity after intravitreal bevacizumab monotherapy","author":"Mintz-Hittner","year":"2016","journal-title":"Ophthalmology"},{"key":"key-10.4103\/2211-5056.250964-28","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00006982-200306000-00006","article-title":"Features associated with surgical outcome in patients with stages 4 and 5 retinopathy of prematurity","author":"Hartnett","year":"2003","journal-title":"Retina"},{"key":"key-10.4103\/2211-5056.250964-29","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1097\/IAE.0b013e3181ca146b","article-title":"Vitrectomy after intravitreal bevacizumab (Avastin) for retinal detachment in retinopathy of prematurity","author":"Kychenthal","year":"2010","journal-title":"Retina"}],"container-title":["Taiwan Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:43:49Z","timestamp":1786715029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.tjo_62_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"alternative-id":["250964"],"URL":"https:\/\/doi.org\/10.4103\/tjo.tjo_62_18","relation":{},"ISSN":["2211-5056"],"issn-type":[{"value":"2211-5056","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}